Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Point72 Asset Management and Array Biopharma Inc (ARRY)

Array Biopharma Inc (NASDAQ:ARRY): Steve Cohen’s Point72 Asset Management filed an amended 13D.

You can check out Point72 Asset Management’s latest holdings and filings here.

Please follow Point72 Asset Management (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Point72 Asset Management or update its stock holdings.

Steve Cohen
Steve Cohen
Point72 Asset Management

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Point7 0 9,172,507 0 9,172,507 9,172,507 5.4%
Point7 0 9,172,507 0 9,172,507 9,172,507 5.4%
Cubist Systematic Strategies 0 21,611 0 21,611 21,611 Less%
Steven A. Cohen 0 9,194,118 0 9,194,118 9,194,118 5.4%
Steve Cohen
Steve Cohen
Point72 Asset Management

Page 1 of 9 – SEC Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*

ARRAY BIOPHARMA INC.


(Name of Issuer)

Common Stock, Par Value $0.001 Per Share


(Title of Class of Securities)
04269X105
(CUSIP Number)
September 11, 2017
(Date of Event which Requires Filing
of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!

Page 2 of 9 – SEC Filing

CUSIP No. 04269X105
13G
Page  2  of  9  Pages
1
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Point72 Asset Management, L.P.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐
(b) ☒
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH:
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
9,172,507 (see Item 4)
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
9,172,507 (see Item 4)
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,172,507 (see Item 4)
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 ☐
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 5.4% (see Item 4)
12
TYPE OF REPORTING PERSON*
PN
*SEE INSTRUCTION BEFORE FILLING OUT

Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!

Page 3 of 9 – SEC Filing

CUSIP No. 04269X105
13G
Page  3  of  9  Pages
1
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Point72 Capital Advisors, Inc.
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐
(b) ☒
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH:
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
9,172,507 (see Item 4)
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
9,172,507 (see Item 4)
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,172,507 (see Item 4)
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 ☐
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 5.4% (see Item 4)
12
TYPE OF REPORTING PERSON*
CO
*SEE INSTRUCTION BEFORE FILLING OUT

Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!

Page 4 of 9 – SEC Filing

CUSIP No. 04269X105
13G
Page  4  of  9  Pages
1
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Cubist Systematic Strategies, LLC
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐
(b) ☒
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH:
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
21,611 (see Item 4)
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
21,611 (see Item 4)
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
21,611 (see Item 4)
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 ☐
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
Less than 0.1% (see Item 4)
12
TYPE OF REPORTING PERSON*
OO
*SEE INSTRUCTION BEFORE FILLING OUT

Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!

Page 5 of 9 – SEC Filing

CUSIP No. 04269X105
13G
Page  5  of  9  Pages
1
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steven A. Cohen
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐
(b) ☒
3
SEC USE ONLY
4
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH:
5
SOLE VOTING POWER
0
6
SHARED VOTING POWER
9,194,118 (see Item 4)
7
SOLE DISPOSITIVE POWER
0
8
SHARED DISPOSITIVE POWER
9,194,118 (see Item 4)
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9,194,118 (see Item 4)
10
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 ☐
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 5.4%  (see Item 4)
12
TYPE OF REPORTING PERSON*
IN
*SEE INSTRUCTION BEFORE FILLING OUT

Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!

Page 6 of 9 – SEC Filing

Item 1(a)
Name of Issuer:
Array BioPharma Inc.
Item 1(b)
Address of Issuer’s Principal Executive Offices:
3200 Walnut Street, Boulder, CO 80301
Item 2(a)
Name of Person Filing:
This statement is filed by: (i) Point72 Asset Management, L.P. (“Point72 Asset Management”) with respect to shares of common stock, par value $0.001 per share (“Shares”), of the Issuer held by certain investment funds it manages; (ii) Point72 Capital Advisors, Inc. (“Point72 Capital Advisors Inc.”) with respect to Shares held by certain investment funds managed by Point72 Asset Management; (iii) Cubist Systematic Strategies, LLC (“Cubist Systematic Strategies”) with respect to Shares held by certain investment funds it manages; and (iv) Steven A. Cohen with respect to Shares beneficially owned by Point72 Asset Management, Point72 Capital Advisors Inc., and Cubist Systematic Strategies.
Point72 Asset Management, Point72 Capital Advisors Inc., Cubist Systematic Strategies, and Steven A. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.
Item 2(b)
Address or Principal Business Office:
The address of the principal business office of (i) Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902; and (ii) Cubist Systematic Strategies is 330 Madison Avenue, New York, NY 10173.
Item 2(c)
Citizenship:
Point72 Asset Management is a Delaware limited partnership.  Point72 Capital Advisors Inc. is a Delaware corporation.  Cubist Systematic Strategies is a Delaware limited liability company.  Mr. Cohen is a United States citizen.
Item 2(d)
Title of Class of Securities:
Common Stock, par value $0.001 per share
Item 2(e)
CUSIP Number:
04269X105
Item 3
Not Applicable

Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!

Page 7 of 9 – SEC Filing

Item 4
Ownership:
The percentages used herein are calculated based upon the Shares issued and outstanding as of August 4, 2017, as reported on the Issuer’s annual report on Form 10-K/A filed with the Securities and Exchange Commission by the Issuer for the fiscal year ended June 30, 2017.
As of the close of business on September 11, 2017:
1.  Point72 Asset Management, L.P.
(a) Amount beneficially owned: 9,172,507
(b) Percent of class:  5.4%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 9,172,507
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 9,172,507
2.  Point72 Capital Advisors, Inc.
(a) Amount beneficially owned: 9,172,507
(b) Percent of class:  5.4%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 9,172,507
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 9,172,507
3.  Cubist Systematic Strategies, LLC
(a) Amount beneficially owned: 21,611
(b) Percent of class: less than 0.1%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 21,611
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 21,611
4. Steven A. Cohen
(a) Amount beneficially owned: 9,194,118
(b) Percent of class:  5.4%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 9,194,118
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition: 9,194,118
Point72 Asset Management, Point72 Capital Advisors Inc., Cubist Systematic Strategies, and Mr. Cohen own directly no Shares.  Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power with respect to the securities held by certain investment funds it manages.  Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management.  Pursuant to an investment management agreement, Cubist Systematic Strategies maintains investment and voting power with respect to the securities held by certain investment funds it manages.  Mr. Cohen controls each of Point72 Capital Advisors Inc. and Cubist Systematic Strategies. By reason of the provisions of Rule 13d-3 of the Securities Exchange Act of 1934, as amended, each of (i) Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen may be deemed to beneficially own 9,172,507 Shares (constituting approximately 5.4% of the Shares outstanding); and (ii) Cubist Systematic Strategies and Mr. Cohen may be deemed to beneficially own 21,611 Shares (constituting less than 0.1% of the Shares outstanding).  Each of Point72 Asset Management, Point72 Capital Advisors Inc., Cubist Systematic Strategies, and Mr. Cohen disclaims beneficial ownership of any of the securities covered by this statement.

Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!

Page 8 of 9 – SEC Filing

Item 5
Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following.  ☐
Item 6
Ownership of More than Five Percent on Behalf of Another Person:
Not Applicable
Item 7
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:
Not Applicable
Item 8
Identification and Classification of Members of the Group:
Not Applicable
Item 9
Notice of Dissolution of Group:
Not Applicable
Item 10
Certification:
By signing below the signatory certifies that, to the best of his knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!

Page 9 of 9 – SEC Filing

SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: September 12, 2017
POINT72 ASSET MANAGEMENT, L.P.
By:  /s/ Kevin J. O’Connor                   
Name:  Kevin J. O’Connor
Title:  Authorized Person
POINT72 CAPITAL ADVISORS, INC.
By:  /s/ Kevin J. O’Connor                   
Name:  Kevin J. O’Connor
Title:  Authorized Person

CUBIST SYSTEMATIC STRATEGIES, LLC

By:  /s/ Kevin J. O’Connor                   
Name:  Kevin J. O’Connor
Title:  Authorized Person

STEVEN A. COHEN

By:  /s/ Kevin J. O’Connor                   
Name:  Kevin J. O’Connor
Title:  Authorized Person

 

Page 9 of 9
Follow Array Biopharma Inc (NASDAQ:ARRY)
Trade (NASDAQ:ARRY) Now!